New Polymorphous Forms Of Rifaximin, Processes For Their Production And Use Thereof In The Medicinal Preparations

Patent No. EP1698630 (titled "New Polymorphous Forms Of Rifaximin, Processes For Their Production And Use Thereof In The Medicinal Preparations") was filed by Alfasigma on Mar 3, 2005. The application was issued on Sep 3, 2014.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
SANDOZJun 3, 2015TER MEER UND PARTNER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP1698630

ALFASIGMA
Application Number
EP05004695A
Filing Date
Mar 3, 2005
Status
Revoked
Nov 27, 2020
Publication Date
Sep 3, 2014